FIG. 1.

Effect of the topical aldose reductase inhibitor (ARI) Kinostat™ and nutraceutical antioxidants Ocu-GLO™ and Optixcare EH administration on the progression of sugar cataract formation in young (100 g) streptozotocin-induced diabetic rats. Administration of topical ARI from the onset of diabetes prevented sugar cataract formation, while similar administration of nutraceutical antioxidants delayed the onset and progression of sugar cataracts, with the topical nutraceutical Optixcare EH demonstrating a greater delay. Values represent mean±standard error of the mean (SEM); n=5.